WHO launches COVID vaccine insurance scheme for 92 low-income countries

The vaccination plan is co-led by the World Health Organization

Brussels, Belgium:

A vaccination program co-led by the World Health Organization is setting up a compensation fund for people in poor countries who may suffer side effects from COVID-19 vaccines.

The mechanism is to avoid the deferred recurrence recorded ten years ago during the H1N1 swine flu pandemic, when vaccination was slowed down in dozens of low-income countries without a clear obligation.

The plan is being put in place by the promoters of the COVAX vaccination facility, co-led by the Global Alliance for Immunization, WHO and GAVI, a COVAX document released Thursday. COVAX aims to deliver at least 2 billion effective snapshots worldwide by the end of next year.

The plan could introduce bills for 92 low-income countries, mostly in Africa and Southeast Asia, meaning their governments would have little to no cost of patient claims, COVAX Something so unexpected must occur after a vaccine delivered by. .

However, dozens of middle-income countries like South Africa, Lebanon, Gabon, Iran and most Latin American states will not benefit from this protection.

COVAX said: “The COVAX facility is developing a system to provide compensation to one of the 92 people in the economy… who are suffering from unanticipated SAEs (serious adverse events).”

The criteria used to select 92 countries were not clearly defined.

Checked in

Although adverse effects from a vaccine that has received regulatory approval are rare, the public is increasingly concerned about COVID-19 injections, given the record rate at which they are being developed – a risk that insurance finance Was exposed by the creation of.

There is no internationally accepted COVID-19 vaccine yet, but the WHO estimates that the virus could be ready for the first time in December, barely a year after the virus first appeared in China. It usually takes years to develop vaccines.

As part of the compensation scheme, countries using COVAX vaccines will sentence drug manufacturers until at least July 2022.

COVAX said vaccine manufacturers were reluctant to supply vaccines for distribution in countries that did not grant them liability protection.

Instead of insurers, who cover these costs under normal circumstances, potential compensation for victims of side effects will be paid through a new mechanism designed by COVAX.

COVAX said the no-fault system will make lump sum payments based on the severity of harm to victims from side effects associated with the administration of COVID-19 vaccines.

COVAX said the mechanism would have a tax on other potential sources, including vaccines distributed to poor countries and contributions from vaccine manufacturers. However, it was not clear who would be required to pay the levy.

The plan could prevent potential victims from going through the courts in search of compensation, resulting in a lengthy process and potentially very high liability costs.

(Except for the title, this story was not edited by NDTV staff and posted from a syndicated feed.)

Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: